Recurrent Breast Cancer Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00733408Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerTreatment
NCT00821964Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerTreatment